Abstract
This report describes two hypogammglobulinemic patients with persistentCampylobacter jejuni infections in spite of IgG substitution and antibiotic therapy. Since serum bactericidal activity (SBA) depends on IgM, these patients were each treated with six doses of an IgM-containing immunoglobulin preparation (Pentaglobin) at three-week intervals. During IgG therapy SBA was not seen in either patient. However, one hour following administration of the IgM preparation SBA increased to 90 %. Just before the next dose SBA was still at the 30–70 % level. Both patients tolerated the therapy very well and there were no culture-confirmed relapses ofCampylobacter jejuni infection. The IgM preparation may therefore be a useful alternative to conventional IgG in the treatment of hypogammaglobulinemic patients with persistentCampylobacter jejuni infection.
Similar content being viewed by others
References
Berkman SA, Lee ML, Gale RP: Clinical use of intravenous immunoglobulins. Annals of Internal Medicine 1990, 112: 278–292.
Blaser MJ, Reller LB:Campylobacter enteritis. New England Journal of Medicine 1981, 305: 1444–1452.
Blaser MJ, Perez Perez G, Smith PF, Patton C, Tenover FC, Lastovica AJ, Wang WIL: Extra intestinalCampylobacter jejuni andCampylobacter coli infections: host factors and strain characteristics. Journal of Infectious Diseases 1986, 153: 552–559.
Spelman DW, Davidson N, Buckmaster ND, Spicer WJ, Ryan P:Campylobacter bacteriaemia: a report of 10 cases. Medical Journal of Australia 1986, 145: 503–505.
Kerstens PJSM, Endtz HPH, Meis JFGM, Oyen WJG, Koopman RJI, Van den Brock PJ, Van der Meer JWM: Erysipelas-like skin lesions associated withCampylobacter jejuni septicemia in patients with hypogammaglobulinemia. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 842–847.
Haque KN, Zaidi MH, Bahakim H: IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. American Journal of Diseases of Children 1988, 142: 1293–1296.
Sternberg JC: A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clinical Chemistry 1977, 23: 1456–1464.
McCabe WR, DeMaria A, Berberich H, Johns MA: Immunization with rough mutants ofSalmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant. Journal of Infectious Diseases 1988, 158: 291–300.
Blaser MJ, Smith PF, Kohler PF: Susceptibility ofCampylobacter isolates to the bactericidal activity of human serum. Journal of Infectious Diseases 1985, 151: 227–235.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Borleffs, J.C.C., Schellekens, J.F., Brouwer, E. et al. Use of an immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with PersistentCampylobacter jejuni infection. Eur. J. Clin. Microbiol. Infect. Dis. 12, 772–775 (1993). https://doi.org/10.1007/BF02098467
Issue Date:
DOI: https://doi.org/10.1007/BF02098467